Spain· ES:109514024
ZEBINIX 50 MG/ML SUSPENSION ORAL
A medicinal product containing eslicarbazepina, registered in Spain by Bial Portela & Ca S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- eslicarbazepina
- Manufacturer
- Bial Portela & Ca S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo720073200EUR 38.36
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eslicarbazepina in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZebinix 50 mg/mlBIAL - Portela & Cª
- CzechiaZEBINIXBIAL - Portela & Ca., SA, S. Mamede do Coronado
- FinlandZebinixBial Portela & C, S.A.
- IrelandZebinix 50 mg/ml Oral suspensionBIAL-Portela & Ca, S.A.
- IcelandZebinixBial - Portela & C. S.A.
- NetherlandsZebinix 50 mg/ml, suspensie voor oraal gebruikBIAL - Portela & C, S.A.
- NorwayZebinixBial
- PolandZebinixBIAL - Portela & Ca. SA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Eslibon
- Bulgaria · Еслибон
- Cyprus · Esran
- Czechia · Eslibon, Eslikarbazepin Neuraxpharm
- Germany · Eslibon, Eslicarbazepin Al
- Denmark · Arupsan, Eslicarbazepinacetat "stada"
- France · Eslicarbazepine 800, Eslicarbazepine Arrow
- United Kingdom (Northern Ireland) · Arupsan, Eslicarbazepine Amarox
- Greece · Esran
- Hungary · Eslicarbazepine 800
- Iceland · Eslicarbazepin, Eslicarbazepine Acetate Stada
- Italy · Arupsan, Eslicarbazepina Acetato Aurobindo
- Liechtenstein · Zebinix
- Malta · Esran
- Netherlands · Eslibon
- Norway · Zebinix
- Poland · Eslibon
- Portugal · Acetato De Eslicarbazepina Alter, Acetato De Eslicarbazepina Aristo
- Sweden · Arupsan
- Slovakia · Eslibon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4dcb2f18-f1e5-4030-98d9-424b8f55ca91 GET /v1/drugs/4dcb2f18-f1e5-4030-98d9-424b8f55ca91?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1514986726000}",
"nregistro": "109514024",
"substance": "eslicarbazepina"
}See everything about eslicarbazepina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.